KHRN.V - Khiron Life Sciences Corp.
| Previous Close | 1.8200 |
| Open | 1.8500 |
| Bid | 1.7600 x 0 |
| Ask | 1.7800 x 0 |
| Day's Range | 1.7500 - 1.8500 |
| 52 Week Range | 0.8800 - 4.3500 |
| Volume | 442,488 |
| Avg. Volume | 483,044 |
| Market Cap | 187.106M |
| Beta (3Y Monthly) | 4.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4360 |
| Earnings Date | May 30, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.58 |
- CNW Group
Khiron Provides Progress Update on Fully Operational and GMP Compliant Colombian Lab Facilities
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ...
- Market Exclusive
Cannabis Stock News Daily Roundup August 21
Cannabis provider Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) announced the sale of certain of its assets in Florida and substantially all of its assets in Ohio. The company is selling 36 acres of land, comprising its Chestnut Hill Tree Farm site in Alachua County, Florida, as well as all of its assets in Ohio, […]The post Cannabis Stock News Daily Roundup August 21 appeared first on Market Exclusive.
- Simply Wall St.
How Khiron Life Sciences Corp. (CVE:KHRN) Could Add Value To Your Portfolio
I've been keeping an eye on Khiron Life Sciences Corp. (CVE:KHRN) because I'm attracted to its fundamentals. Looking...
- CNW Group
Khiron Announces DTC Eligibility, Increasing Access for U.S. Investors
TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
- CNW Group
Khiron Provides Clarification of August 12, 2019 News Release
TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
- CNW Group
Khiron Boosts European Expansion With Key Executive Appointments
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...
- CNW Group
Khiron Launches Revenue-Generating Pilot Program With Top Colombian Health Insurance Provider
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate ...
- Baystreet
Heightened Interest in Hemp-Infused Beauty Products as Large Conglomerates Enter Space
As the wave of positive reviews roll in, hemp-infused beauty products containing the non-psychoactive ...
